C.R. Bard Transvaginal Mesh Claims Center at Gilman Law LLP Urges Alleged Victims of Vaginal Mesh Complications to Seek Legal Advice Immediately

Business Wire


The C.R. Bard Transvaginal Mesh Claims Center at Gilman Law LLP is urging any woman who suffered serious complications associated with the company’s pelvic mesh devices to seek legal advice immediately. C.R. Bard, Inc. is facing thousands of transvaginal mesh lawsuits in courts around the country, all of which have been filed on behalf of women who experienced painful and debilitating injuries following implantation of vaginal mesh products to treat pelvic organ prolapse and stress urinary incontinence. Two C.R. Bard vaginal mesh lawsuits have already gone to trial, and ended with multi-million dollar judgments in favor of the plaintiffs.

Attorneys with Gilman Law’s C.R. Bard Transvaginal Mesh Claims Center believe that alleged victims of vaginal mesh complications could be entitled to significant financial compensation. However, the litigation involving C.R. Bard is moving forward quickly, and potential plaintiffs must act now to ensure their right to recover damages is preserved. To that end, Gilman Law is offering free, no-obligation legal consultations to women who may have been injured by a C.R. Bard mesh product, including:

  • Avaulta Plus™ BioSynthetic Support System
  • Avaulta Solo™ Synthetic Support System
  • Faslata® Allograft
  • Pelvicol® Tissue
  • PelviSoft® Biomesh
  • Pelvitex™ Polypropylene Mesh

Anyone seeking legal assistance with their C.R. Bard transvaginal mesh claim is encouraged to contact Gilman Law LLP as soon as possible by calling TOLL FREE at 888-252-0048, or submit a free legal consultation form online at the firm’s website.

C.R. Bard is named a defendant in more than 5,000 transvaginal mesh lawsuits now pending in a multidistrict litigation underway in U.S. District Court, Southern District of West Virginia. This past summer, the first bellwether trial of a C.R. Bard case ended with a victim of an Avaulta mesh device being awarded $2 million in damages. The case selected for the litigation’s second bellwether trial was reportedly settled for an undisclosed amount, while the third was voluntarily dismissed by the plaintiff. The next bellwether trial involving a C.R. Bard transvaginal mesh claim is set to begin in January. (In re C.R. Bard Inc. Pelvic Repair System Products Liability Litigation, MDL No. 2187)

One other C.R. Bard vaginal mesh lawsuit went to trial in California State Court in July 2012. The jury awarded $5.5 million to the Plaintiff, and ordered C.R. Bard to pay a $3.6 million portion of the judgment. (Scott v. Kannappan, S-1500-CV-266034-WDE, Superior Court for Kern County, California (Bakersfield))

The Food & Drug Administration (FDA) issued its first communication regarding the dangers associated with transvaginal mesh in October 2008, and followed up with a second public warning in July 2011. According to the FDA, transvaginal mesh complications following pelvic organ prolapse repair are not rare. What’s more, the agency also stated that it is “not clear that transvaginal POP repair with mesh is any more effective than traditional [transvaginal surgery without mesh] … and may expose patients to greater risk.”


On September 30, 2013, Bloomberg News reported that C.R. Bard was in talks to settle thousands of the transvaginal mesh claims currently pending against the company.


About Gilman Law LLP

Gilman Law LLP, a leading consumer law firm with offices in Florida and Massachusetts, has been recognized for delivering successful results to their clients across a broad range of claims stemming from consumer product injury, mass tort, and class action lawsuits. For over 32 years, the Gilman Law LLP team of highly experienced lawyers has earned renown for tireless work on behalf of their clients on many of today's most challenging and important legal issues.

Gilman Law LLP
Kenneth G. Gilman, 1-888-252-0048

View Comments